This agreement as part of the IReL consortium, covers the period of the 1 Apr 2021 – 31 Dec 2024. It will allow accepted articles In more than 2,000 Springer Hybrid Journals from current UL staff or students to be made open access immediately upon publication.
NOTE: This agreement has a limited OA quota per year. We expect it to be used up by the end of the year. Any updates will be posted on this page.
UPDATE (5th September 2022): Springer Nature OA quota has now been fully used up. From this time until the end of 2022, authors will not be offered IReL-funded OA when their article is accepted for publication.
This agreement gives authors from IReL affiliated Institutions a fixed allowance of articles that can be made Open Access. We estimate that approximately 80% of articles will be covered by this.
In addition, you can enjoy full access to all Springer subscription journal content.
IReL projections estimate that this fund will run out in late August 2022.
The agreement covers over 2000 Springer Hybrid journals. A full list of these is available in the spreadsheet below.
It excludes Open Access Journals and Journals undergoing a transformative process to full Open Access. The Nature Journals are all going through the transformative process therefore they are excluded from this agreement.
BioMed Central (BMC) journals are fully Open Access and are excluded from this deal.
Which article types are covered by this agreement?
If you are the corresponding author you can follow the steps below
Corresponding authors must be a current staff member or student of UL.
In the article submission process you must correctly identify your institution.
You should use your UL email address when submitting your article.
If your manuscript is accepted for publication, the publisher will give you the opportunity to make your article Open Access and apply a Creative Commons license. The publisher will then contact the participating institution to confirm your eligibility under the agreement.